| Revenue and Practice Management |
1 |
1 |
| Breast Cancer |
0 |
0.8 |
| Insurance |
0 |
0.77 |
| Care and Maintenance of Vision |
0 |
0.46 |
| Cataract |
0 |
0.33 |
| Lung Cancer |
0 |
0.33 |
| A-Scan Biometry |
0 |
0.27 |
| Positron Emission Tomography |
0 |
0.27 |
| Scan |
0 |
0.27 |
| Biologic Therapy |
0 |
0.23 |
| Cancer |
0 |
0.22 |
| HER2/Neu |
0 |
0.22 |
| Antineoplastic Drug |
0 |
0.21 |
| Chemotherapy |
0 |
0.16 |
| Florida |
0 |
0.16 |
| Preventive Screening |
0 |
0.16 |
| Adjuvant Chemotherapy |
0 |
0.15 |
| Breast Mass |
0 |
0.12 |
| Tobacco Cessation |
0 |
0.12 |
| Biopsy |
0 |
0.11 |
| Blood |
0 |
0.11 |
| Breast |
0 |
0.11 |
| Clinical Guidelines |
0 |
0.11 |
| Dorsum |
0 |
0.11 |
| Heart |
0 |
0.11 |
| Lung |
0 |
0.11 |
| Smoking |
0 |
0.11 |
| Drug Costs |
0 |
0.06 |
| Estrogen |
0 |
0.06 |
| Fever |
0 |
0.06 |
| Financial Reimbursement |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Humanized Monoclonal Antibody |
0 |
0.06 |
| Leukemia |
0 |
0.06 |
| Lymph Node |
0 |
0.06 |
| Lymphoma |
0 |
0.06 |
| Nurse Practitioners |
0 |
0.06 |
| Psychology |
0 |
0.06 |
| Rare Diseases |
0 |
0.06 |
| Receptors |
0 |
0.06 |
| Stress |
0 |
0.06 |
| Surgery |
0 |
0.06 |